Cassone, Giulia
 Distribuzione geografica
Continente #
NA - Nord America 5.246
EU - Europa 2.594
AS - Asia 1.091
OC - Oceania 67
SA - Sud America 58
AF - Africa 41
Continente sconosciuto - Info sul continente non disponibili 5
Totale 9.102
Nazione #
US - Stati Uniti d'America 5.155
IT - Italia 767
GB - Regno Unito 648
SE - Svezia 376
CN - Cina 282
SG - Singapore 208
DE - Germania 196
HK - Hong Kong 175
FI - Finlandia 117
FR - Francia 101
TR - Turchia 97
UA - Ucraina 95
JP - Giappone 87
BG - Bulgaria 69
IE - Irlanda 60
AU - Australia 59
CA - Canada 51
IN - India 49
ID - Indonesia 47
LT - Lituania 34
PK - Pakistan 32
VN - Vietnam 29
MX - Messico 28
TN - Tunisia 28
KR - Corea 23
MY - Malesia 19
NL - Olanda 19
AR - Argentina 18
PL - Polonia 18
RU - Federazione Russa 17
BZ - Belize 12
PE - Perù 12
HU - Ungheria 11
PT - Portogallo 11
BE - Belgio 10
ES - Italia 10
IR - Iran 10
BR - Brasile 9
CL - Cile 9
NZ - Nuova Zelanda 8
CO - Colombia 7
RO - Romania 7
EG - Egitto 6
AT - Austria 5
JO - Giordania 5
PH - Filippine 5
TW - Taiwan 5
CZ - Repubblica Ceca 4
DK - Danimarca 4
EU - Europa 4
IL - Israele 4
LU - Lussemburgo 4
RS - Serbia 4
SA - Arabia Saudita 4
EC - Ecuador 3
BD - Bangladesh 2
CH - Svizzera 2
DZ - Algeria 2
KE - Kenya 2
KH - Cambogia 2
LV - Lettonia 2
NP - Nepal 2
ZA - Sudafrica 2
A1 - Anonimo 1
CY - Cipro 1
GR - Grecia 1
HR - Croazia 1
IQ - Iraq 1
KG - Kirghizistan 1
MA - Marocco 1
MM - Myanmar 1
NO - Norvegia 1
Totale 9.102
Città #
Fairfield 853
Chandler 507
Ashburn 474
Southend 451
Woodbridge 341
Houston 281
Seattle 267
Nyköping 264
Wilmington 259
Cambridge 240
Ann Arbor 215
Hong Kong 162
Singapore 149
Jacksonville 142
Dearborn 110
Modena 110
Helsinki 98
San Diego 95
New York 89
Sofia 69
Beijing 68
Princeton 68
Redwood City 64
Milan 61
London 50
Perth 46
Jakarta 44
Bremen 39
Eugene 36
Izmir 36
Shanghai 35
Dublin 32
Rome 31
Falls Church 25
San Jose 25
Los Angeles 23
Tokyo 23
Bologna 20
Chicago 19
Dong Ket 18
Boardman 17
Bari 15
Munich 15
Reggio Nell'emilia 13
Belize City 12
Catania 12
Ottawa 12
Moscow 11
Mumbai 11
Norwalk 11
Buffalo 10
Frankfurt am Main 10
Guangzhou 10
Menlo Park 10
Toronto 10
Brussels 9
Gangnam-gu 9
Hamilton 9
Hounslow 9
Las Vegas 9
Bolu 8
Cagliari 8
Kilburn 8
Louisville 8
Santiago 8
Debrecen 7
Hangzhou 7
Kolkata 7
Manchester 7
Parma 7
Phoenix 7
San Francisco 7
Wuhan 7
Ahmedabad 6
Amsterdam 6
Atlanta 6
Bogotá 6
Casarano 6
Chiclayo 6
Chiswick 6
Columbus 6
Dallas 6
Florence 6
Gloucester 6
Istanbul 6
Lyon 6
Mexico City 6
Nagoya 6
Ankara 5
Buenos Aires 5
Caserta 5
Cremona 5
Duncan 5
Hefei 5
Ho Chi Minh City 5
Jinan 5
Monza 5
Nanjing 5
Napoli 5
Saint Louis 5
Totale 6.409
Nome #
Epidemiology and management of interstitial lung disease in ANCA-associated vasculitis 894
Diagnostic accuracy of a velcro sound detector (VECTOR) for interstitial lung disease in rheumatoid arthritis patients: The InSPIRAtE validation study (INterStitial pneumonia in rheumatoid ArThritis with an electronic device) 261
Analysis of pulmonary sounds for the diagnosis of interstitial lung diseases secondary to rheumatoid arthritis 251
Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: results from the GISEA register 226
Combination Therapy with Nintedanib and Sarilumab for the Management of Rheumatoid Arthritis Related Interstitial Lung Disease 209
Carotidynia Possibly due to Localized Vasculitis in a Patient with Latent Mycobacterium tuberculosis Infection. 208
Gynaecological Screening for Cervical and Vulvar Malignancies in a Cohort of Systemic Sclerosis Patients: Our Experience and Review of the Literature 208
NEW PERSPECTIVES IN DIAGNOSIS OF INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. VALIDATION STUDY OF AN ELECTRONIC STETHOSCOPE AND AD HOC SOFTWARE FOR DETECTION OF PULMONARY CRACKLES 207
Serum 25-OH vitamin D levels in systemic sclerosis: analysis of 140 patients and review of the literature 201
Nailfold capillaroscopic changes in dermatomyositis and polymyositis 195
Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: A prospective study and review of the literature 180
[18F]fluorodeoxyglucose positron emission tomography imaging in a case of relapsing polychondritis 175
Prevalence and characterization of non-sicca onset primary Sjögren syndrome with interstitial lung involvement 171
Tocilizumab therapy in rheumatoid arthritis with interstitial lung disease: a multicenter retrospective study 171
Nailfold Capillaroscopy Characteristics of Antisynthetase Syndrome and Possible Clinical Associations: Results of a Multicenter International Study 163
Measuring microangiopathy abnormalities in systemic sclerosis patients: the role of capillaroscopy-based scoring models 159
INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. WHAT DO WE DON’T KNOW? THE LIRA STUDY (LUNG INVOLVEMENT IN RHEUMATOID ARTHRITIS) 152
Neurologic Complications Associated with Sjögren's Disease: Case Reports and Modern Pathogenic Dilemma 150
Severe alopecia complicating systemic sclerosis 147
Factors Predicting Early Failure of Etanercept in Rheumatoid Arthritis: An Analysis From the Gruppo Italiano di Studio sulla Early Arthritis (Italian Group for the Study of Early Arthritis) Registry 147
Tocilizumab for the treatment of patients with rheumatoid arthritis and interstitial lung diseases: a case series 143
AB1157 VALIDATION OF VECTOR (VELCRO CRACKLES DETECTOR) FOR THE DIAGNOSIS OF INTERSTITIAL LUNG DISEASE IN PATIENTS WITH CONNECTIVE TISSUE DISEASES 143
Nailfold videocapillaroscopy in antisynthetase syndrome 142
Safety of Abatacept in Italian Patients with Rheumatoid Arthritis and Interstitial Lung Disease: A Multicenter Retrospective Study 135
COST ANALYSIS RELATED TO SUBCUTANEOUS IMMUNOGLOBULINS IN PATIENTS WITH INFLAMMATORY MYOPATHIES AND IMMUNE-MEDIATED CHRONIC NEUROPATHIES. RESULTS OF AN OPEN LABEL STUDY 133
Interstitial pneumonia with autoimmune features: A single center prospective follow-up study 132
Therapeutic Options for the Treatment of Interstitial Lung Disease Related to Connective Tissue Diseases. A Narrative Review 132
Interstitial lung disease is associated to infections of lower respiratory tract in immunocompromised rheumatoid arthritis patients 128
Caratteristiche cliniche e nuovi orizzonti diagnostico-terapeutici delle vasculiti dei grandi vasi e della interstiziopatia polmonare secondaria ad artrite reumatoide. 126
Efficacy and safety of mycophenolate mofetil in the treatment of rheumatic disease-related interstitial lung disease: a narrative review 126
PAP-TEST FEATURES IN A COHORT OF SYSTEMIC SCLEROSIS PATIENTS 125
Rituximab therapy for primary central nervous system vasculitis: A 6 patient experience and review of the literature 124
INTERSTITIAL LUNG DISEASE IS ASSOCIATED TO INFECTIONS OF LOWER RESPIRATORY TRACT IN IMMUNOCOMPROMISED RHEUMATOID ARTHRITIS PATIENTS 123
AB0472 PRIMARY SJOGREN SYNDROME ASSOCIATED INTERSTITIAL LUNG DISEASE: FEATURES, TREATMENT AND OUTCOME OF A MONOCENTRIC COHORT 121
Efficacy and safety of rituximab in the treatment of connective tissue disease-related interstitial lung disease 116
Granulomatosis with polyangiitis presenting as a renal mass successfully treated with rituximab 113
Pirfenidone for the treatment of interstitial lung disease associated to rheumatoid arthritis: a new scenario is coming? 108
High-dose glucocorticoids pulse-Therapy for beta-coronaviridae pneumonia: A systematic literature review and case-series of coronavirus disease-2019 107
Treatment of Rheumatoid Arthritis-Associated Interstitial Lung Disease: Lights and Shadows 105
Treatment with Rituximab in Systemic Sclerosis Patients: Our Experience in a Pilot Clinical Trial 104
NAILFOLD CAPILLAROSCOPIC ALTERATIONS IN DERMATOMYOSITIS AND POLYMYOSITIS 104
FRI0613 THERAPEUTIC STRATEGIES AND SURVIVAL IN PATIENTS WITH INTERSTITIAL PNEUMONIA WITH AUTOIMMUNE FEATURES 91
Lung involvement in systemic sclerosis: role of high resolution computed tomography and its relationship with other pulmonary and clinico-serological features. 89
Interstitial pneumonia with autoimmune features: Why rheumatologist–pulmonologist collaboration is essential 86
VECTOR: An algorithm for the detection of COVID-19 pneumonia from velcro-like lung sounds 84
Erratum: Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: A prospective study and review of the literature (Journal of Thoracic Disease (2019) 11 (1621-1628) DOI: 10.21037/jtd.2019.03.28) 79
The rediscovery of hydroxychloroquine in allergic diseases in the covid-19 era 77
Pathogenesis and treatment of idiopathic and rheumatoid arthritis-related interstitial pneumonia. The possible lesson from COVID-19 pneumonia 74
Predictive factors of clinical outcomes in patients with COVID-19 treated with tocilizumab: A monocentric retrospective analysis 74
The impact of chest CT body composition parameters on clinical outcomes in COVID-19 patients 73
Human Dental Pulp Stem Cells Modulate Cytokine Production in vitro by Peripheral Blood Mononuclear Cells From Coronavirus Disease 2019 Patients 73
Usefulness of digital velcro crackles detection in identification of interstitial lung disease in patients with connective tissue diseases 73
Susceptibility and severity of COVID-19 in patients treated with bDMARDS and tsDMARDs: A population-based study 69
Susceptibility to COVID-19 in Patients Treated With Antimalarials: A Population-Based Study in Emilia-Romagna, Northern Italy 69
Erratum to: Prevalence and characterization of non-sicca onset primary Sjögren syndrome with interstitial lung involvement (Clinical Rheumatology, (2017), 36, 6, (1261-1268), 10.1007/s10067-017-3601-1) 67
Tofacitinib for the Treatment of Severe Interstitial Lung Disease Related to Rheumatoid Arthritis 67
Interstitial lung disease and anti-myeloperoxidase antibodies: not a simple association 65
Diagnosis, Clinical Features and Management of Interstitial Lung Diseases in Rheumatic Disorders: Still a Long Journey 64
Significance of PR3-ANCA positivity in eosinophilic granulomatosis with polyangiitis (Churg-Strauss) 62
Fibrosing interstitial lung disease in primary Sjogren syndrome 60
Acute-phase reactants during tocilizumab therapy for severe COVID-19 pneumonia 58
Therapeutic Strategies and Survival in Patients with Interstitial Pneumonia with Autoimmune Features 51
Rheumatoid arthritis related interstitial lung disease 51
EVALUATION OF INTERNAL CONSISTENCY, FEASIBILITY, AND RELIABILITY OF THE ITALIAN VERSION OF ANCA-ASSOCIATED VASCULITIS PATIENT-REPORTED OUTCOME (AAV-PRO_ITA) QUESTIONNAIRE: PRELIMINARY RESULTS FROM A MULTICENTER STUDY ON A LARGE COHORT OF ITALIAN PATIENTS 49
SAT0470 Pap-Test Features in a Cohort of Systemic Sclerosis Patients 49
Interstitial lung disease in microscopic polyangiitis and granulomatosis with polyangiitis: demographic, clinical, serological and radiological features of an Italian cohort from the Italian Society for Rheumatology 47
Risk of acute arterial and venous thromboembolic events in eosinophilic granulomatosis with polyangiitis (Churg–Strauss syndrome) 47
Pneumopathie interstitielle fibrosante dans le syndrome de Gougerot-Sjögren primitif 45
Tocilizumab or glucocorticoids treatment for patients with SARS-CoV-2 pneumonia: An observational study 42
Arthritis in Systemic Lupus Erythematosus: From 2022 International GISEA/OEG Symposium 39
Age at diagnosis influences the clinical phenotype, treatment strategies and outcomes in patients with giant cell arteritis: results from the observational GCAGE study on a large cohort of 1004 patients 34
Reply to the comment on: Hypereosinophilic bronchiolitis in ANCA-associated vasculitis: where does it stand? by Bilgin et al 30
CHARACTERIZATION OF ANTI-MPO POSITIVE INTERSTITIAL LUNG DISEASE. CLINICAL-SEROLOGIC AND RADIOLOGIC FEATURES AND SURVIVAL 28
Axial Spondyloarthritis: Reshape the Future—From the “2022 GISEA International Symposium” 26
Classification of pulmonary sounds through deep learning for the diagnosis of interstitial lung diseases secondary to connective tissue diseases 25
Radiomics to predict the mortality of patients with rheumatoid arthritis-associated interstitial lung disease: A proof-of-concept study 23
CLINICAL OUTCOMES OF TREATMENT WITH GOLIMUMAB IN SEROPOSITIVE AND SERONEGATIVE RHEUMATOID ARTHRITIS PATIENTS IN REAL-LIFE SETTINGS. DATA FROM ITALIAN REGISTER GISEA 21
EFFICACY OF EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS TREATMENTS ACCORDING TO THE TYPE OF MANIFESTATIONS BASED ON ANALYSIS OF 636 PATIENTS 18
117. PREDICTION OF LONG-TERM EVOLUTIONARY PROFILES IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (CHURG– STRAUSS) BASED ON BASELINE AND FOLLOW-UP CHARACTERISTICS 17
FRI0212 THE ROLE OF AGE ON THE CLINICAL PRESENTATION AND RELAPSE RATES IN A LARGE COHORT OF 720 PATIENTS WITH GIANT CELL ARTERITIS 17
From Bench to Bedside in Rheumatoid Arthritis from the “2022 GISEA International Symposium” 17
354. EFFICACY OF EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS TREATMENTS ACCORDING TO THE TYPE OF MANIFESTATIONS BASED ON ANALYSIS OF 636 PATIENTS 17
Rheumatoid Arthritis from Easy to Complex Disease: From the "2022 GISEA International Symposium" 16
PREDICTION OF LONG-TERM EVOLUTIONARY PROFILES IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (CHURG-STRAUSS) BASED ON BASELINE AND FOLLOW-UP CHARACTERISTICS 15
Fibrosing Progressive Interstitial Lung Disease in Rheumatoid Arthritis: A Multicentre Italian Study 13
Reactive Granulomatous Dermatitis during Anti-TNF Therapy: A Case Report and Review of the Literature 10
EARLY DISCONTINUATION OF FIRST LINE BIOLOGICAL TREATMENT WITH ETANERCEPT IN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS FROM THE ITALIAN GISEA REGISTRY 9
HARNESSING THE POWER OF RADIOMICS TO PREDICT SURVIVAL IN PATIENTS WITH RA-ILD 9
POS1053 PREVALENCE OF FIBROSING PROGRESSIVE INTERSTITIAL LUNG DISEASE IN RHEUMATOID ARTHRITIS PATIENTS 7
Granuloma annulare as a possible new adverse effect of topiramate 6
NAILFOLD CAPILLAROSCOPY IN ANTISYNTHETASE SYNDROME (NASCAR): RESULTS OF A MULTICENTER, INTERNATIONAL STUDY OF THE AMERICAN AND EUROPEAN NETWORK OF ANTISYNTHETASE SYNDROME (AENEAS) 5
JANUS KINASES INHIBITORS IN CLINICAL PRACTICE IN ITALY. RESULTS FROM A SINGLE CENTER EXPERIENCE 5
Trattamento con Tocilizumab in monoterapia dopo trattamento con glucocorticoidi per breve periodo in pazienti con arterite a cellule giganti con coinvolgimento dei grandi vasi: effetti sui checkpoint immunitari solubili 4
Effects in soluble immune checkpoints induced by Tocilizumab monotherapy after ultra-short-term glucocorticoids in large vessel – giant cell arteritis patients 4
Personalized Medicine and Machine Learning: A Roadmap for the Future 4
Treatment of giant cell arteritis with ultra-short glucocorticoids and tocilizumab: results from the extension of the TOPAZIO study 3
Treatment of giant cell arteritis with ultra-short glucocorticoids and tocilizumab: the role of imaging in a prospective observational study 3
Totale 9.325
Categoria #
all - tutte 49.430
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.430


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.069 0 0 33 63 104 180 183 140 154 91 68 53
2020/20211.900 133 65 134 138 196 135 225 197 184 211 143 139
2021/20221.747 144 106 111 99 91 137 81 91 209 173 321 184
2022/20231.874 211 178 145 138 211 215 87 207 230 47 115 90
2023/20241.590 68 89 75 232 219 125 129 254 47 54 123 175
2024/2025290 143 69 78 0 0 0 0 0 0 0 0 0
Totale 9.325